BidaskScore Reports Bausch Health Companies (BHC) Upgrade; EBRO FOODS SA BARCELONA SPAIN (EBRPF) SI Increased By 0.08%

EBRO FOODS SA BARCELONA SPAIN (OTCMKTS:EBRPF) had an increase of 0.08% in short interest. EBRPF’s SI was 119,700 shares in December as released by FINRA. Its up 0.08% from 119,600 shares previously. It closed at $20.75 lastly. It is up 0.00% since December 4, 2018 and is . It has by 0.00% the S&P500.

In a a note issued to clients on 3 December, expert analysts at BidaskScore’s equity division upgraded Bausch Health Companies (NYSE:BHC)‘s stock to a Buy.

The stock increased 1.87% or $0.53 during the last trading session, reaching $28.8. About 2.63M shares traded. Bausch Health Companies Inc. (NYSE:BHC) has risen 10.41% since December 4, 2018 and is uptrending. It has outperformed by 10.41% the S&P500.

Among 5 analysts covering Bausch Health Companies (NYSE:BHC), 4 have Buy rating, 0 Sell and 1 Hold. Therefore 80% are positive. Bausch Health Companies has $6000 highest and $2800 lowest target. $36.60’s average target is 27.08% above currents $28.8 stock price. Bausch Health Companies had 7 analyst reports since August 7, 2019 according to SRatingsIntel. As per Wednesday, August 7, the company rating was maintained by H.C. Wainwright. The rating was upgraded by TD Securities on Thursday, August 15 to “Buy”. H.C. Wainwright maintained it with “Buy” rating and $6000 target in Monday, December 2 report.

Analysts await Bausch Health Companies Inc. (NYSE:BHC) to report earnings on February, 19. They expect $1.14 earnings per share, up 8.57% or $0.09 from last year’s $1.05 per share. BHC’s profit will be $401.14M for 6.32 P/E if the $1.14 EPS becomes a reality. After $1.19 actual earnings per share reported by Bausch Health Companies Inc. for the previous quarter, Wall Street now forecasts -4.20% negative EPS growth.

Bausch Health Companies Inc. develops, makes, and markets a range of pharmaceutical, medical device, and over-the-counter products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company has market cap of $10.13 billion. It offers dermatology products that treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis, cold sores, athlete's foot, nail fungus, and other dermatoses, as well as provides aesthetic medical devices, which address various conditions, including facial wrinkles, acne, pigmentation conditions, body sculpting, skin tightening, and laser hair removal. It currently has negative earnings. The firm also develops and markets products that treat gastrointestinal and hepatologic conditions comprising hepatic encephalopathy, irritable bowel syndrome with diarrhea, traveler's diarrhea, opioid-induced constipation, ulcerative colitis, and others.

More notable recent Bausch Health Companies Inc. (NYSE:BHC) news were published by: Finance.Yahoo.com which released: “Did Hedge Funds Drop The Ball On Bausch Health Companies (BHC) ? – Yahoo Finance” on December 03, 2019, also Seekingalpha.com with their article: “Bausch Health Companies Inc. (BHC) Management Presents at Evercore ISI 2nd Annual HealthCONx Conference (Transcript) – Seeking Alpha” published on December 04, 2019, Forbes.com published: “Why Did Bausch Health Companies’ [BHC] Stock Jump 50% In 2 Months? – Forbes” on November 22, 2019. More interesting news about Bausch Health Companies Inc. (NYSE:BHC) were released by: Seekingalpha.com and their article: “Bausch Health Companies Inc. (BHC) CEO Joe Papa Presents at Stifel 2019 Healthcare Conference (Transcript) – Seeking Alpha” published on November 20, 2019 as well as Fool.com‘s news article titled: “Bausch Health Companies Inc. (BHC) Q3 2019 Earnings Call Transcript – Motley Fool” with publication date: November 04, 2019.

Ebro Foods, S.A. produces and sells food products in Europe, North America, Asia, and Africa. The company has market cap of $3.33 billion. It operates through three divisions: Rice Business, Pasta Business, and Healthy Food and Organic Business. It currently has negative earnings. The firm produces and distributes rice, rice products, and complementary food products; and fresh and dry pasta, sauces, semolina, and semolina based products.

More news for Ebro Foods, S.A. (OTCMKTS:EBRPF) were recently published by: Seekingalpha.com, which released: “Ebro Foods: A Spanish Company Benefiting From The New U.S. Tax Law – Seeking Alpha” on March 21, 2018. Seekingalpha.com‘s article titled: “Ebro Foods SA ADR 2018 Q2 – Results – Earnings Call Slides – Seeking Alpha” and published on July 25, 2018 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.